At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
1064nm Q-switch Laser +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study Comparing the Efficacy of 1064 Q-switch Laser vs. Glycolic Acid Peels for the Treatment of Melasma: A Randomized Control Trial
In Brief
A clinical study evaluating 1064nm Q-switch Laser and Glycolic Acid Peels for Melanosis. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The purpose of this study is to find out the safety and effectiveness of 1064 Q-Switch Laser Therapy compared to Glycolic Acid Chemical Peels for the treatment of melasma.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMelanosis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartOct 2013
First PostedNov 2013
Primary CompletionJan 2015
TodayJul 2026
First PostedNov 5, 2013
Enrollment StartOct 1, 2013
Primary CompletionJan 7, 2015
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 12.7 years ago
Interventions
1064nm Q-switch Laserdevice
Glycolic Acid Peelsother